Cancer-associated fibroblasts from human NSCLC survive ablative doses of radiation but their invasive capacity is reduced

Radiation Oncology

Volumn 7, Issue 1, 2012, Pages

  Hellevik, Turid ^a   Pettersen, Ingvild ^b   Berg, Vivian ^b   Winberg, Jan O ^b   Moe, Bjørn T ^a   Bartnes, Kristian ^a   Paulssen, Ruth H ^b   Busund, Lill Tove ^a,b   Bremnes, Roy ^a,b   Chalmers, Anthony ^c   Martinez Zubiaurre, Iñigo ^b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Ablative radiation; Cancer associated fibroblasts; Focal adhesion; Integrins; Invasion

Indexed keywords

ALPHA2 INTEGRIN; ALPHA5 INTEGRIN; BETA1 INTEGRIN; CELL SURFACE PROTEIN; INTERSTITIAL COLLAGENASE; STROMELYSIN; TISSUE INHIBITOR OF METALLOPROTEINASE; VINCULIN; INTEGRIN; MATRIX METALLOPROTEINASE;

ADULT; AGED; ARTICLE; CANCER ASSOCIATED FIBROBLAST; CANCER STAGING; CELL INVASION; CELL ISOLATION; CELL MIGRATION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA DAMAGE; DONOR; FEMALE; HUMAN; HUMAN CELL; IONIZING RADIATION; LUNG NON SMALL CELL CANCER; MALE; PROTEIN EXPRESSION; RADIATION DOSE; RADIOSENSITIVITY; BIOSYNTHESIS; CANCER INVASION; CELL ADHESION; CELL AGING; CELL CULTURE; CELL DIVISION; CELL MOTION; ENZYME INDUCTION; EXTRACELLULAR MATRIX; FIBROBLAST; FOCAL ADHESION; GENETICS; LUNG TUMOR; MAGNETIC AND ELECTROMAGNETIC EQUIPMENT; METABOLISM; MIDDLE AGED; PATHOLOGY; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOSURGERY; STROMA CELL;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CELL ADHESION; CELL AGING; CELL DIVISION; CELL MOVEMENT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENZYME INDUCTION; EXTRACELLULAR MATRIX; FEMALE; FIBROBLASTS; FOCAL ADHESIONS; HUMANS; INTEGRINS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASES; MIDDLE AGED; NEOPLASM INVASIVENESS; PARTICLE ACCELERATORS; RADIATION TOLERANCE; RADIOSURGERY; STROMAL CELLS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 84859640872     PISSN: None     EISSN: 1748717X     Source Type: Journal    
DOI: 10.1186/1748-717X-7-59     Document Type: Article

References (44)

1. Heinzerling JH, Kavanagh B, Timmerman RD. Stereotactic ablative radiation therapy for primary lung tumors. Cancer J 2011, 17(1):28-32. 10.1097/PPO.0b013e31820a7f80, 21263264.
2. Palma D, Senan S. Stereotactic radiation therapy: changing treatment paradigms for stage I nonsmall cell lung cancer. Curr Opin Oncol 2011, 23(2):133-139. 10.1097/CCO.0b013e328341ee11, 21107257.
3. Kavanagh BD, Miften M, Rabinovitch RA. Advances in treatment techniques: stereotactic body radiation therapy and the spread of hypofractionation. Cancer J 2011, 17(3):177-181. 10.1097/PPO.0b013e31821f7dbd, 21610471.
4. Bissell MJ, Radisky D. Putting tumours in context. Nat Rev Cancer 2001, 1(1):46-54. 10.1038/35094059, 2975572, 11900251.
5. Bhowmick NA, Neilson EG, Moses HL. Stromal fibroblasts in cancer initiation and progression. Nature 2004, 432(7015):332-337. 10.1038/nature03096, 3050735, 15549095.
6. Kalluri R, Zeisberg M. Fibroblasts in cancer. Nat Rev Cancer 2006, 6(5):392-401. 10.1038/nrc1877, 16572188.
7. Gaggioli C, Hooper S, Hidalgo-Carcedo C, Grosse R, Marshall JF, Harrington K, Sahai E. Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells. Nat Cell Biol 2007, 9(12):1392-1400. 10.1038/ncb1658, 18037882.
8. Chantrain CF, Henriet P, Jodele S, Emonard H, Feron O, Courtoy PJ, DeClerck YA, Marbaix E. Mechanisms of pericyte recruitment in tumour angiogenesis: a new role for metalloproteinases. Eur J Cancer 2006, 42(3):310-318. 10.1016/j.ejca.2005.11.010, 16406506.
9. Shimoda M, Mellody KT, Orimo A. Carcinoma-associated fibroblasts are a rate-limiting determinant for tumour progression. Semin Cell Dev Biol 2010, 21(1):19-25. 10.1016/j.semcdb.2009.10.002, 2828545, 19857592.
10. Mantoni TS, Lunardi S, Al-Assar O, Masamune A, Brunner TB. Pancreatic stellate cells radioprotect pancreatic cancer cells through beta1-integrin signaling. Cancer Res 2011, 71(10):3453-3458. 10.1158/0008-5472.CAN-10-1633, 3097171, 21558392.
11. Hawsawi NM, Ghebeh H, Hendrayani SF, Tulbah A, Al-Eid M, Al-Tweigeri T, Ajarim D, Alaiya A, Dermime S, Aboussekhra A. Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes. Cancer Res 2008, 68(8):2717-2725. 10.1158/0008-5472.CAN-08-0192, 18413739.
12. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, Ji B, Evans DB, Logsdon CD. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res 2008, 68(3):918-926. 10.1158/0008-5472.CAN-07-5714, 2519173, 18245495.
13. Rodier F, Coppé JP, Patil CK, Hoeijmakers WA, Muñoz DP, Raza SR, Freund A, Campeau E, Davalos AR, Campisi J. Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion. Nat Cell Biol 2009, 11(8):973-979. 10.1038/ncb1909, 2743561, 19597488.
14. Ohuchida K, Mizumoto K, Murakami M, Qian LW, Sato N, Nagai E, Matsumoto K, Nakamura T, Tanaka M. Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 2004, 64(9):3215-3222. 10.1158/0008-5472.CAN-03-2464, 15126362.
15. Papadopoulou A, Kletsas D. Human lung fibroblasts prematurely senescent after exposure to ionizing radiation enhance the growth of malignant lung epithelial cells in vitro and in vivo. Int J Oncol 2011, 39(4):989-999.
16. Garcia-Barros M, Paris F, Cordon-Cardo C, Lyden D, Rafii S, Haimovitz-Friedman A, Fuks Z, Kolesnick R. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science 2003, 300(5622):1155-1159. 10.1126/science.1082504, 12750523.
17. Lee Y, Wang Y, Burnette B, Wang Y, Meng Y, Beckett M, Sharma R, Chin R, Tu T, Weichselbaum RR, Fu YX. Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment. Blood 2009, 114(3):589-595. 10.1182/blood-2009-02-206870, 2713472, 19349616.
18. Brown JM, Koong AC. High-dose single-fraction radiotherapy: exploiting a new biology?. Int J Radiat Oncol Biol Phys 2008, 71(2):324-325. 10.1016/j.ijrobp.2008.02.003, 18474308.
19. Xing JZ, Zhu L, Gabos S, Xie L. Microelectronic cell sensor assay for detection of cytotoxicity and prediction of acute toxicity. Toxicol In Vitro 2006, 20(6):995-1004. 10.1016/j.tiv.2005.12.008, 16481145.
20. Atienza JM, Yu N, Kirstein SL, Xi B, Wang X, Xu X, Abassi YA. Dynamic and label-free cell-based assays using the real-time cell electronic sensing system. Assay Drug Dev Technol 2006, 4(5):597-607. 10.1089/adt.2006.4.597, 17115930.
21. Abassi YA, Xi B, Zhang W, Ye P, Kirstein SL, Gaylord MR, Feinstein SC, Wang X, Xu X. Kinetic cell-based morphological screening: prediction of mechanism of compound action and off-target effects. Chem Biol 2009, 16(7):712-723. 10.1016/j.chembiol.2009.05.011, 2836189, 19635408.
22. Eisenberg MC, Kim Y, Li R, Ackerman WE, Kniss DA, Friedman A. Mechanistic modeling of the effects of myoferlin on tumor cell invasion. Proc Natl Acad Sci USA 2011, 108(50):20078-20083. 10.1073/pnas.1116327108, 22135466.
23. Scanlan MJ, Raj BKM, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, Old LJ, Rettig WJ. Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sci USA 1994, 91(12):5657-5661. 10.1073/pnas.91.12.5657, 44055, 7911242.
24. Park JE, Lenter MC, Zimmermann RN, Garin-Chesa P, Old LJ, Rettig WJ. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J Biol Chem 1999, 274(51):36505-36512. 10.1074/jbc.274.51.36505, 10593948.
25. d'Adda di Fagagna F, Reaper PM, Clay-Farrace L, Fiegler H, Carr P, von Zglinicki T, Saretzki G, Carter NP, Jackson SP. A DNA damage checkpoint response in telomere-initiated senescence. Nature 2003, 426(6963):194-198. 10.1038/nature02118, 14608368.
26. Efimova EV, Mauceri HJ, Golden DW, Labay E, Bindokas VP, Darga TE, Chakraborty C, Barreto-Andrade JC, Crawley C, Sutton HG, Kron SJ, Weichselbaum RR. Poly(ADP-ribose) polymerase inhibitor induces accelerated senescence in irradiated breast cancer cells and tumors. Cancer Res 2010, 70(15):6277-6282. 10.1158/0008-5472.CAN-09-4224, 2912962, 20610628.
27. McCarthy JB, Basara ML, Palm SL, Sas DF, Furcht LT. The role of cell adhesion proteins-laminin and fibronectin-in the movement of malignant and metastatic cells. Cancer Metastasis Rev 1985, 4(2):125-152. 10.1007/BF00050692, 3893683.
28. Suzuki M, Boothman DA. Stress-induced premature senescence (SIPS)-influence of SIPS on radiotherapy. J Radiat Res (Tokyo) 2008, 49(2):105-112.
29. Wang D, Jang DJ. Protein kinase CK2 regulates cytoskeletal reorganization during ionizing radiation-induced senescence of human mesenchymal stem cells. Cancer Res 2009, 69(20):8200-8207. 10.1158/0008-5472.CAN-09-1976, 2763327, 19826041.
30. Banath JP, Klokov D, MacPhail SH, Banuelos CA, Olive PL. Residual gammaH2AX foci as an indication of lethal DNA lesions. BMC Cancer 2010, 10:4. 10.1186/1471-2407-10-4, 2819996, 20051134.
31. Coussens LM, Tinkle CL, Hanahan D, Werb Z. MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 2000, 103(3):481-490. 10.1016/S0092-8674(00)00139-2, 2843102, 11081634.
32. Murray GI, Duncan ME, O'Neil P, Melvin WT, Fothergill JE. Matrix metalloproteinase-1 is associated with poor prognosis in colorectal cancer. Nat Med 1996, 2(4):461-462. 10.1038/nm0496-461, 8597958.
33. Holleran WM, Galardy RE, Gao WN, Levy D, Tang PC, Elias PM. Matrix metalloproteinase inhibitors reduce phorbol ester-induced cutaneous inflammation and hyperplasia. Arch Dermatol Res 1997, 289(3):138-144. 10.1007/s004030050169, 9128761.
34. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999, 98(2):137-146. 10.1016/S0092-8674(00)81009-0, 2853255, 10428026.
35. Martin MD, Matrisian LM. The other side of MMPs: protective roles in tumor progression. Cancer Metastasis Rev 2007, 26(3-4):717-724. 10.1007/s10555-007-9089-4, 17717634.
36. Kessenbrock K, Plaks V, Werb Z. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010, 141(1):52-67. 10.1016/j.cell.2010.03.015, 2862057, 20371345.
37. Desgrosellier JS, Cheresh DA. Integrins in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 2010, 10(1):9-22. 10.1038/nrc2748, 20029421.
38. Hynes RO. Integrins: bidirectional, allosteric signaling machines. Cell 2002, 110(6):673-687. 10.1016/S0092-8674(02)00971-6, 12297042.
39. Caswell PT, Vadrevu S, Norman JC. Integrins: masters and slaves of endocytic transport. Nat Rev Mol Cell Biol 2009, 10(12):843-853. 10.1038/nrm2799, 19904298.
40. Teckchandani A, Toida N, Goodchild J, Henderson C, Watts J, Wollscheid B, Cooper JA. Quantitative proteomics identifies a Dab2/integrin module regulating cell migration. J Cell Biol 2009, 186(1):99-111. 10.1083/jcb.200812160, 2712992, 19581412.
41. Friedl P, Wolf K. Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer 2003, 3(5):362-374. 10.1038/nrc1075, 12724734.
42. Cordes N, Seidler J, Durzok R, Geinitz H, Brakebusch C. beta1-integrin-mediated signaling essentially contributes to cell survival after radiation-induced genotoxic injury. Oncogene 2006, 25(9):1378-1390. 10.1038/sj.onc.1209164, 16247454.
43. Zhang Z, Vuori K, Reed JC, Ruoslahti E. The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci USA 1995, 92(13):6161-6165. 10.1073/pnas.92.13.6161, 41662, 7541142.
44. Park CC, Zhang HJ, Yao ES, Park CJ, Bissell MJ. Beta1 integrin inhibition dramatically enhances radiotherapy efficacy in human breast cancer xenografts. Cancer Res 2008, 68(11):4398-4405. 10.1158/0008-5472.CAN-07-6390, 18519702.